Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Sci Rep ; 14(1): 11820, 2024 05 23.
Article in English | MEDLINE | ID: mdl-38783007

ABSTRACT

Aglaonema commutatum is a famous species in the Aglaonema genus, which has important ornamental and economic value. However, its chloroplast genome information and phylogenetic relationships among popular green cultivars of Aglaonema in southern China have not been reported. Herein, chloroplast genomes of one variety of A. commutatum and seven green cultivars of Aglaonema, namely, A. commutatum 'San Remo', 'Kai Sa', 'Pattaya Beauty', 'Sapphire', 'Silver Queen', 'Snow White', 'White Gem', and 'White Horse Prince', were sequenced and assembled for comparative analysis and phylogeny. These eight genomes possessed a typical quadripartite structure that consisted of a LSC region (90,799-91,486 bp), an SSC region (20,508-21,137 bp) and a pair of IR regions (26,661-26,750 bp). Each genome contained 112 different genes, comprising 79 protein-coding genes, 29 tRNA genes and 4 rRNA genes. The gene orders, GC contents, codon usage frequency, and IR/SC boundaries were highly conserved among these eight genomes. Long repeats, SSRs, SNPs and indels were analyzed among these eight genomes. Comparative analysis of 15 Aglaonema chloroplast genomes identified 7 highly variable regions, including trnH-GUG-exon1-psbA, trnS-GCU-trnG-UCC-exon1, trnY-GUA-trnE-UUC, psbC-trnS-UGA, trnF-GAA-ndhJ, ccsA-ndhD, and rps15-ycf1-D2. Reconstruction of the phylogenetic trees based on chloroplast genomes, strongly supported that Aglaonema was a sister to Anchomanes, and that the Aglaonema genus was classified into two sister clades including clade I and clade II, which corresponded to two sections, Aglaonema and Chamaecaulon, respectively. One variety and five cultivars, including A. commutatum 'San Remo', 'Kai Sa', 'Pattaya Beauty', 'Silver Queen', 'Snow White', and 'White Horse Prince', were classified into clade I; and the rest of the two cultivars, including 'Sapphire' and 'White Gem', were classified into clade II. Positive selection was observed in 34 protein-coding genes at the level of the amino acid sites among 77 chloroplast genomes of the Araceae family. Based on the highly variable regions and SSRs, 4 DNA markers were developed to differentiate the clade I and clade II in Aglaonema. In conclusion, this study provided chloroplast genomic resources for Aglaonema, which were useful for its classification and phylogeny.


Subject(s)
Genome, Chloroplast , Phylogeny , Genomics/methods , Genetic Markers , Chloroplasts/genetics , Base Composition , Microsatellite Repeats/genetics
2.
World J Clin Cases ; 10(29): 10501-10515, 2022 Oct 16.
Article in English | MEDLINE | ID: mdl-36312469

ABSTRACT

BACKGROUND: Hepatocellular carcinoma (HCC) is a common malignancy worldwide, and the mortality rate continues to rise each year. SMARCA4 expression has been associated with poor prognosis in various types of cancer; however, the specific mechanism of action of SMARCA4 in HCC needs to be fully elucidated. AIM: To explore the specific mechanism of action of SMARCA4 in HCC. METHODS: Herein, the expression level of SMARCA4 as well as its association with HCC prognosis were evaluated using transcriptome profiling and clinical data of 18 different types of cancer collected from The Cancer Genome Atlas database. Furthermore, SMARCA4-high and -low groups were identified. Thereafter, gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed to identify the function of SMARCA4, followed by construction of a SMARCA4-specific competing endogenous RNA (ceRNA) network using starBase database. The role of SMARCA4 in immunotherapy and its association with immune cells were assessed using correlation analysis. RESULTS: It was observed that SMARCA4 was overexpressed and negatively correlated with prognosis in HCC. Further, SMARCA4 expression was positively associated with tumor mutational burden, microsatellite stability, and immunotherapy efficacy. The SNHG3/THUMP3-AS1-miR-139-5p-SMARCA4 ceRNA network was established and could be assumed to serve as a stimulatory mechanism in HCC. CONCLUSION: The findings of this study demonstrated that SMARCA4 plays a significant role in progression and immune infiltration in HCC. Moreover, a ceRNA network was detected, which was found to be correlated with poor prognosis in HCC. The findings of this study could contribute towards the identification of predictive markers for immunotherapy and a novel mechanism of action for HCC treatment.

3.
J Inorg Biochem ; 203: 110905, 2020 02.
Article in English | MEDLINE | ID: mdl-31707333

ABSTRACT

Marbofloxacin (MB) is a newly developed veterinary drug with broad-spectrum antibacterial activity. In this study, a new calcium(II)-based complex of marbofloxacin, MB-Ca, was synthesized and structurally characterized by IR, ESI-MS, UV-Vis and single crystal X-ray diffraction analysis. The characterization of this complex in solution state indicated that the coordinated MB-Ca was partly retained, along with the monomeric and dimeric forms of MB. It also showed satisfactory water solubility (1.89 mg/mL), comparing with MB (2.82 mg/mL) at 35 °C. The in vitro antibacterial activity of MB-Ca was also screened towards a series of typical pathogenic bacteria, and determined by the methods of turbidimetry and disc diffusion. The results indicated it showed comparable antibacterial activity to MB. However, it exhibited higher inhibitive ability in vitro on DNA gyrase than MB alone. Furthermore, MB-Ca showed significantly lower acute toxicity (LD50, 3186 mg/kg) than MB (LD50, 1294 mg/kg) in mice, based on the in vivo acute toxicity test. The histopathological examination on the major organs of the mice by the oral administration of MB-Ca did not show obvious organic lesions, which is similar to those treated by MB. The research results suggest that MB-Ca could be further developed into a new promising metal-based veterinary drug and a better substitute of MB, showing unabated antibacterial activity along with lower toxicity.


Subject(s)
Anti-Bacterial Agents/chemical synthesis , Calcium/chemistry , Coordination Complexes/chemical synthesis , Fluoroquinolones/chemistry , Hepatocytes/drug effects , Organometallic Compounds/chemical synthesis , Animals , Anti-Bacterial Agents/toxicity , Bacteria/drug effects , Coordination Complexes/toxicity , Mice , Organometallic Compounds/toxicity
4.
Biomed Res Int ; 2013: 417278, 2013.
Article in English | MEDLINE | ID: mdl-23862145

ABSTRACT

PURPOSE: Dual-energy CT imaging tends to suffer from much lower signal-to-noise ratio than single-energy CT. In this paper, we propose an improved anticorrelated noise reduction (ACNR) method without causing cross-contamination artifacts. METHODS: The proposed algorithm diffuses both basis material density images (e.g., water and iodine) at the same time using a novel correlated diffusion algorithm. The algorithm has been compared to the original ACNR algorithm in a contrast-enhanced, IRB-approved patient study. Material density accuracy and noise reduction are quantitatively evaluated by the percent density error and the percent noise reduction. RESULTS: Both algorithms have significantly reduced the noises of basis material density images in all cases. The average percent noise reduction is 69.3% and 66.5% with the ACNR algorithm and the proposed algorithm, respectively. However, the ACNR algorithm alters the original material density by an average of 13% (or 2.18 mg/cc) with a maximum of 58.7% (or 8.97 mg/cc) in this study. This is evident in the water density images as massive cross-contaminations are seen in all five clinical cases. On the contrary, the proposed algorithm only changes the mean density by 2.4% (or 0.69 mg/cc) with a maximum of 7.6% (or 1.31 mg/cc). The cross-contamination artifacts are significantly minimized or absent with the proposed algorithm. CONCLUSION: The proposed algorithm can significantly reduce image noise present in basis material density images from dual-energy CT imaging, with minimized cross-contaminations compared to the ACNR algorithm.


Subject(s)
Artifacts , Signal-To-Noise Ratio , Tomography, X-Ray Computed , Algorithms , Humans , Radiographic Image Enhancement , Radiography, Abdominal
5.
Zhonghua Nan Ke Xue ; 14(4): 371-6, 2008 Apr.
Article in Chinese | MEDLINE | ID: mdl-18481435

ABSTRACT

OBJECTIVE: To investigate the effects of Ginkgo biloba extract (EGB) on the testosterone synthesis in the Leydig cells of type 2 diabetic rats. METHODS: Thirty male SD rats were equally randomised into a normal control, a type 2 diabetic and an EGB group. Morphological changes of Leydig cells were observed by light microscopy (LM) and transmission electron microscopy (TEM), concentrations of serum luteinizing hormone (LH) and testosterone (T) were determined by enzyme linked immunosorbent assay (ELISA), and the mRNA levels in the steroidogenic acute regulatory protein (StAR), cytochrome P450 side chain cleavage (P450scc), cytochrome P450 17a-hydroxylase (P450c17), 17beta-hydroxysteroid dehydrogenase 3 (17beta-HSD3) and 3beta-hydroxysteroid dehydrogenase (3beta-HSD1) from the Leydig cells were examined by RT-PCR. RESULTS: Compared with the normal control, there was a significant decrease in the number and volume of Leydig cells, the levels of serum LH and T and the expression of mRNA in StAR, P450scc, 17beta-HSD3 and 3beta-HSD1 in the type 2 diabetes group. And the expression of the P450c17 gene showed a tendency of descending, but with no significance. Compared with the type 2 diabetes group, 12 weeks of EGB treatment caused very slight pathological changes in the Leydig cells, significantly increased the concentrations of blood LH and T, markedly elevated the levels of mRNA in StAR and P450scc and induced an ascending tendency of the expressions of P450c17, 17beta-HSD3 and 3beta-HSD1. CONCLUSION: EGB enhances testosterone synthesis and secretion of Leydig cells by reducing the impairment of the testis in type 2 diabetic rats.


Subject(s)
Diabetes Mellitus, Type 2/physiopathology , Ginkgo biloba/chemistry , Leydig Cells/drug effects , Plant Extracts/pharmacology , Testosterone/biosynthesis , 17-Hydroxysteroid Dehydrogenases/genetics , Animals , Cholesterol Side-Chain Cleavage Enzyme/genetics , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/genetics , Enzyme-Linked Immunosorbent Assay , Gene Expression/drug effects , Hydroxysteroid Dehydrogenases/genetics , Leydig Cells/metabolism , Leydig Cells/ultrastructure , Luteinizing Hormone/blood , Male , Microscopy, Electron, Transmission , Phosphoproteins/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Testosterone/blood
6.
Eur J Cancer ; 44(11): 1596-602, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18492607

ABSTRACT

Chronic infection of hepatitis B virus (HBV) is one of the major causes of hepatocellular carcinoma (HCC) in the world. The hepatitis B virus X protein (HBx) is implicated in HCC development, although its oncogenic role remains controversial. HBx is a multifunctional regulator that modulates transcription, signal transduction, cell cycle progress, and DNA repair by directly or indirectly interacting with host factors. We constructed the HBx stably expressing HepG2 cell line to investigate the impact of HBx on intra-S-phase checkpoint induced by mitomycin C (MMC). The HBx transformed HepG2 cells are more sensitive to MMC treatment and showed defective radioresistant DNA synthesis compared to the control cell line transformed with empty vector. With DNA content assay, HBx transformed cells showed defective S phase arrest and a consequent G2/M arrest after MMC treatment. HBx impaired the ATR dependent phosphorylation of Chk1 and monoubiquitination of FANCD2. Overexpression of ATR reverted the MMC induced phenotype of Chk1 and FANCD2 in HBx transformed cells. The defect of intra-S-phase checkpoint resulted in accumulation of genomic instability. In conclusion, HBx disrupts intra-S-phase checkpoint induced by MMC through ATR-Chk1 and ATR-FANCD2 pathways.


Subject(s)
DNA Damage/drug effects , Mitomycin/pharmacology , Nucleic Acid Synthesis Inhibitors/pharmacology , S Phase/drug effects , Trans-Activators/pharmacology , Carcinoma, Hepatocellular/virology , Checkpoint Kinase 1 , Hepatitis B, Chronic/complications , Humans , Liver Neoplasms/virology , Protein Kinases/metabolism , Viral Regulatory and Accessory Proteins
SELECTION OF CITATIONS
SEARCH DETAIL
...